BBIO
Overvalued by 123.5% based on the discounted cash flow analysis.
Market cap | $6.50 Billion |
---|---|
Enterprise Value | $5.98 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-2.88 |
Beta | 1.15 |
Outstanding Shares | 190,145,253 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -9.75 |
---|---|
PEG | -2.6 |
Price to Sales | - |
Price to Book Ratio | -4.26 |
Enterprise Value to Revenue | 46.97 |
Enterprise Value to EBIT | -8.87 |
Enterprise Value to Net Income | -9 |
Total Debt to Enterprise | 0 |
Debt to Equity | -0.01 |
No data
No data